To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission.

Lee HY, Ong WS, Tjan-Heijnen V, Lambertini M, Lu YS, Park KH, Sagara Y, Vidal M, Urruticoechea A, Oliveira M, Ciruelos E, Zdenkowski N, Bedard PL, Ignatiadis M, Lee SC, Sohn J, Zaman K, Werutsky G, Curigliano G, O'Reilly S, Tsang J, Kim SB, Saji S, Ohno S, Adam V, Arahmani A, Caballero C, Yap YS

Open source

DOI: 10.1016/j.breast.2026.104935
Published: 2026 Oct 12
Container: Breast (Edinburgh, Scotland)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.breast.2026.104935,
  title = {To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission.},
  author = {Lee HY and Ong WS and Tjan-Heijnen V and Lambertini M and Lu YS and Park KH and Sagara Y and Vidal M and Urruticoechea A and Oliveira M and Ciruelos E and Zdenkowski N and Bedard PL and Ignatiadis M and Lee SC and Sohn J and Zaman K and Werutsky G and Curigliano G and O'Reilly S and Tsang J and Kim SB and Saji S and Ohno S and Adam V and Arahmani A and Caballero C and Yap YS},
  year = {2026},
  journal = {Breast (Edinburgh, Scotland)},
  doi = {10.1016/j.breast.2026.104935},
  url = {https://doi.org/10.1016/j.breast.2026.104935}
}

RIS

TY  - JOUR
TI  - To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission.
AU  - Lee HY
AU  - Ong WS
AU  - Tjan-Heijnen V
AU  - Lambertini M
AU  - Lu YS
AU  - Park KH
AU  - Sagara Y
AU  - Vidal M
AU  - Urruticoechea A
AU  - Oliveira M
AU  - Ciruelos E
AU  - Zdenkowski N
AU  - Bedard PL
AU  - Ignatiadis M
AU  - Lee SC
AU  - Sohn J
AU  - Zaman K
AU  - Werutsky G
AU  - Curigliano G
AU  - O'Reilly S
AU  - Tsang J
AU  - Kim SB
AU  - Saji S
AU  - Ohno S
AU  - Adam V
AU  - Arahmani A
AU  - Caballero C
AU  - Yap YS
PY  - 2026
JO  - Breast (Edinburgh, Scotland)
DO  - 10.1016/j.breast.2026.104935
UR  - https://doi.org/10.1016/j.breast.2026.104935
ER  -

APA

HY, L., WS, O., V, T., M, L., YS, L., KH, P., Y, S., M, V., A, U., M, O., E, C., N, Z., PL, B., M, I., SC, L., J, S., K, Z., G, W., G, C., S, O., J, T., SB, K., S, S., S, O., V, A., A, A., C, C., & YS, Y. (2026). To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission.. Breast (Edinburgh, Scotland). https://doi.org/10.1016/j.breast.2026.104935

Source records

pubmed · retrieved 2026-11-10T12:02:32.212Z